Science fiction genre in the context of popular culture and high culture discussions
2020
0 views
0 downloads
Advisor: Prof. Dr. Melda Üner
Abstract (EN)
The concept of value in literature is an issue that has been thought upon since the very old times. Distinctions between the popular culture and the high culture have been one of the determining standards of this value for a long time. Subject-matter of this dissertation is an evaluation of the science fiction genre with reference to the dis-cussions over popular culture and high culture. To do this, I first presented the change in our reading habits over a period from the 15th century to the 20th century, address-ing the relationship between the modernism and the high culture. Then I elucidated the views of the critics about the popular culture during the modernism and post-modernism era. I evaluated the literary genres in general and the science fiction genre in particular under the light of these discussions. In the final section, I examined two science fiction novels, Hunger Games and Kingdom Come, within the context of popular culture and high culture.
Author
Bihter Oy
Institution
How to Cite
Bihter Oy (Master Thesis). Science fiction genre in the context of popular culture and high culture discussions, 2020, Yeditepe University.
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)